MYD88 and B-cell chronic lymphocytic leukemia: Our results confirm that CLL cases with mutations in MYD88 are significantly enriched in gene expression signatures related to cytokines and inflammation, such as NF-κB and STAT3 signaling, as well as high basal cytokine secretion, which is in accordance with previous reports in CLL [12] and DLBCL [8].